Evidence map›Paper›PMID 35017208›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2022

The Minority Scientists' Experience: Challenging and Overcoming Barriers to Enhancing Diversity and Career Advancement.

Tonya J Webb, Mireia Guerau-de-Arellano, Harlan P Jones, Cherié L Butts, Luis Sanchez-Perez, Luis J Montaner

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Reaffirming DEI as a central value of JCM.Journal of clinical microbiology · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Tonya J WebbDepartment of Microbiology and Immunology, University of Maryland School of Medicine and the Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD; twebb@som.umaryland.edu.ORCID 0000-0003-3086-6414
Mireia Guerau-de-ArellanoSchool of Health and Rehabilitation Sciences, Department of Microbial Infection and Immunity and Institute of Behavioral Medicine Research, The Ohio State University, Columbus, OH.ORCID 0000-0002-0600-4593
Harlan P JonesInstitute for Health Disparities, University of North Texas Health Science Center, Fort Worth, TX.ORCID 0000-0003-3248-0355
Cherié L ButtsTherapeutics Development Unit, Biogen, Cambridge, MA; and.ORCID 0000-0002-9211-9396
Luis Sanchez-PerezTune Therapeutics, Durham, NC; and.
Luis J MontanerThe Wistar Institute, Philadelphia, PA.ORCID 0000-0001-5799-6759
Biogen (United States) · USInstitute for Behavioral Medicine · USThe Wistar Institute · USTriangle Universities Nuclear Laboratory · USUniversity of Maryland, Baltimore · USUniversity of North Texas · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Upstream Regulation and Downstream effectors of c-MYC in Ovarian CancerU54MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Abiel Roche-Lima · 2017 to 2026
$35.8M
TRAINING PROGRAM IN BASIC CANCER RESEARCHT32CA009171 · NCI · WISTAR INSTITUTE · PI Alessandro Gardini · 1985 to 2026
$15.3M
TRAINING IN HIV PATHOGENESIST32AI007632 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Frederic D Bushman, James L. Riley · 2000 to 2026
$10.6M
Shared Resources CoreU54CA190158 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2014 to 2023
$4.2M
UMB Postbaccalaureate Research Education ProgramR25GM113262 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M, CAREY, GREGORY B · 2016 to 2025
$3.2M
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunityR01AI121405 · NIAID · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA · 2016 to 2020
$2.2M
Novel Epigenetic Modifier Inhibitor Drugs for T cell Modulation in Multiple SclerosisR21AI127354 · NIAID · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA · 2017 to 2018
$404k
Novel knockout models to analyze CD38 functionR03AI151769 · NIAID · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA · 2020 to 2021
$156k
NCI NIH HHS P30 CA010815NCI NIH HHS P30 CA134274NCI NIH HHS T32 CA009171NCI NIH HHS U54 CA190158NIAID NIH HHS R01 AI121405NIAID NIH HHS R03 AI151769NIAID NIH HHS R21 AI127354NIAID NIH HHS T32 AI007632NIGMS NIH HHS R25 GM113262NIMHD NIH HHS U54 MD007600
6 · The paper itself

Abstract

Minority groups face barriers in accessing quality health care, professional advancement, and representation in immunology research efforts as a result of institutional racism that if unaddressed can perpetuate a lack of diversity. In 2021, the AAI Minority Affairs Committee convened a cross section of academic and industry scientists from underrepresented groups at various stages of their professions to discuss how best to address the toll racism takes on study design and scientific careers. Panelists drew directly from their own experiences as scientists to share perspectives and strategies for countering a lack of representation in clinical research, responding to microaggressions, navigating academic advancement, and providing effective mentorship. The session reinforced the need for minority scientists to take an active role in advocating for diversity, engaging mentors, and taking responsibility to face rather than avoid institutional obstacles. Overall, increased dialogue and institutional awareness of the experience of scientists from underrepresented groups in research remain the best tools to ensure a health equity mindset and advancement of their careers.

Indexed as

Academic SuccessCareer MobilityBiomedical ResearchCultural DiversityHumansMentoringMentorsMicroaggressionMinority GroupsResearch PersonnelSexual and Gender MinoritiesSystemic Racism

Identifiers

PMID35017208
PMCPMC9206815
OpenAlexW4205830097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.